Company News

For more information about the history of the company and our technology, click here.

$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants
XCONOMY: When Novartis dissolved its gene and cell therapy unit a few years ago, a bunch of projects the Swiss...  READ MORE
Regenerex gets new CEO, new funding and new name: Talaris Therapeutics
FIERCE BIOTECH: As it gears up to move its lead cell therapy into phase 3, Regenerex has closed a $100...  READ MORE
Local researchers celebrate medical breakthrough in post-transplant care
WDRB.Com | LOUISVILLE, Ky. (WDRB) — A group of local researchers plan to use a $100 million Series A financing...  READ MORE
On a mission to make organ transplants safer and more durable, Blackstone gifts Talaris a new CEO, leads $100M round
ENDPOINTS NEWS: As a transplant surgeon by training, Suzanne Ildstad understood the plight of her patients all too well: The...  READ MORE